drugset / Trial / NCT04194645
A Study in Healthy Men to Test How the Body Takes up and Tolerates Different Doses of BI 474121, and Whether it Makes a Difference if BI 474121 is Taken as a Tablet or a Drink.
RandomizedParallel-groupSingle-blindTreatment
Summary
The main objectives of this trial are to investigate safety, tolerability and pharmacokinetics (PK) of BI 474121 in healthy male subjects following oral administration of single rising doses.
Timeline
- Start
- 2020-01-09
- Primary completion
- 2021-03-25
- Completion
- 2021-03-25
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | BI 474121 | Unknown | 0.25 mg | Oral |
| Subject | BI 474121 | Unknown | 1 mg | Oral |
| Subject | BI 474121 | Unknown | 2.5 mg | Oral |
| Subject | BI 474121 | Unknown | 5 mg | Oral |
| Subject | BI 474121 | Unknown | 10 mg | Oral |
| Subject | BI 474121 | Unknown | 20 mg | Oral |
| Subject | BI 474121 | Unknown | 40 mg | Oral |
Indications
No indication recorded.